Delivery Order SPE2DB24D1205-SPE2DB25FDASR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,186.93 to AmerisourceBergen Drug Corp for 100 units of ZENPEP DR 40,000 capsules. This competitive award was issued on August 15, 2025, with an ultimate completion date of August 18, 2025, and is structured as a firm fixed-price delivery order. The contractor will perform fulfillment from its corporate office location in Conshohocken, Pennsylvania. ZENPEP is a pancreatic enzyme replacement therapy used to treat pancreatic...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for ZENPEP DR 40,000 unit capsules (100-count bottles) with a ceiling value of $4,127.11. This firm fixed price delivery order, which achieves ultimate completion on July 24, 2025, represents a competitively awarded non-set-aside contract with performance at the vendor's Conshohocken, Pennsylvania location. ZENPEP is a pancreatic enzyme replacement therapy used to treat pancreatic...
- The Defense Logistics Agency awarded a $9,447.87 delivery order to AmerisourceBergen Drug Corp for 100 capsule bottles of Zenpep DR 40,000 unit strength. The contract, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, employs firm fixed price pricing with no set-aside designation, indicating competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 20,000 unit capsules of ZENPEP DR 100s, with a ceiling value of $4,456.61. This delivery order, issued June 30, 2025 with an ultimate completion date of July 1, 2025, represents a firm fixed price, competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,127.68 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of 4,564,242,620 ZENPEP DR 15,000 UNIT CAPSULES 100S, a pharmaceutical product, with a performance period through April 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to...
- This is a $1,275.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4,565,296,656 units of ZENPEP DR 10,000 UNIT CAPSULE 100S, a pharmaceutical product. The award has an ultimate completion date of July 31, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through...
- This is a $9,017.93 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,908,548 units of the drug ZENPEP DR 40,000 UNIT CAPSULE 100S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ZENPEP DR 40,000 UNIT CAPSULE 100S. The order has a firm fixed price of $17,434.88 and a period of performance through May 30, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,199.06 contract is for the supply of 4,567,790,837 units of the drug ZENPEP (40,000 units per capsule, 100 capsules per bottle). The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 4,561,437,257 ZENPEP DR 20,000 unit capsules. The firm-fixed-price contract, valued at $1,637.27, has a completion date of July 10, 2023. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDASRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,778.20 to AmerisourceBergen Drug Corp for ZENPEP DR 40,000 Unit Capsule 100s on September 19, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside provisions, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. ZENPEP is a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency, reflecting the breadth of specialized pharmaceutical products that AmerisourceBergen supplies to federal healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen leverages this comprehensive global pharmaceutical support vehicle to deliver a wide range of medications, vaccines, and medical supplies to military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The company's consistent receipt of competitively awarded delivery orders demonstrates its established capability to meet federal procurement requirements across diverse therapeutic domains and supply volumes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 9/19/25 |